Drugs by condition
Drugs approved for chronic myeloid leukemia
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
13
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
7
New molecular entities and new biologics
In development
6
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for chronic myeloid leukemia.
All approved drugs for chronic myeloid leukemia, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 29 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Kinase Inhibitor (2)
Antimetabolite (1)
- Droxia Hydroxyurea · Waylis Therap · 1967
Class not listed in FDA's data (10)
- Scemblix Asciminib Hydrochloride · Novartis · 2021
- Blincyto Blinatumomab · Amgen · 2014
- Iclusig Ponatinib Hydrochloride · Takeda Pharms USA · 2012
- Bosulif Bosutinib Monohydrate · Pf Prism Cv · 2012
- Tasigna Nilotinib Hydrochloride · Novartis · 2007
- Sprycel Dasatinib · Bristol Myers Squibb · 2006
- Imkeldi Imatinib Mesylate · Shorla Oncology · 2024
- Phyrago Dasatinib · Handa Therap · 2023
- Bosulif Bosutinib Monohydrate · Pf Prism Cv · 2023
- Gleevec Imatinib Mesylate · Novartis · 2003
Drugs in development for chronic myeloid leukemia
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- OlverembatinibPhase 34 trials
Ascentage Pharma Group Inc. · Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed/Refractory Acute Myeloid Leukaemia
- RadotinibSupect, IY5511Phase 33 trials
Il-Yang Pharm. Co., Ltd. · Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory
- HS-10382MK-4208, Tern-701Phase 32 trials
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase
- TGRX-678Phase 32 trials
Shenzhen TargetRx Co., Ltd. · Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myeloid Leukemia
- ELVN-001Phase 31 trial
Enliven Therapeutics · Chronic Myeloid Leukemia (CML), Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive, Chronic Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive CML
- FlumatinibPhase 31 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia
1 discontinued brand-name drugs whose label still names it
- Nilotinib D-Tartrate Nilotinib D-Tartrate
More on chronic myeloid leukemia: recruiting trials · published research
Related in hematology and blood cancers: Multiple myeloma · Acute myeloid leukemia · Chronic lymphocytic leukemia · Acute lymphoblastic leukemia · Lymphoma (non-Hodgkin) · Hodgkin lymphoma · Myelodysplastic syndromes · Myelofibrosis · Sickle cell disease · Hemophilia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.